| Ms Carol B Myers, OT | |
|
2121 Mesa Dr, Boulder, CO 80304-3621 | |
| (720) 565-2693 | |
| Not Available |
| Full Name | Ms Carol B Myers |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2121 Mesa Dr, Boulder, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598960163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | AA473488 (Colorado) | Primary |
| Provider Name | Covell Care And Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063695351 PECOS PAC ID: 9335223429 Enrollment ID: O20080228000078 |
News Archive
A team led by Fengzhi Li, PhD, and Xinjiang Wang, PhD, of Roswell Park Cancer Institute has reported new findings regarding therapeutic targets of the novel anticancer agent FL118. Previous studies from these researchers have showed that FL118 induces cancer cell death, or apoptosis, by inhibiting expression of multiple cell-survival proteins (survivin, Mcl-1, XIAP or cIAP2).
BHR Pharma, LLC (BHR) announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its proprietary BHR-100 intravenous progesterone infusion product.
Memorial Sloan-Kettering Cancer Center (MSKCC) today celebrated a new outpatient chemotherapy center, which is scheduled to open later this month, pending approval from the State Department of Health. The 7,745-square-foot facility, called the Brooklyn Infusion Center, will provide leading-edge chemotherapy services to current MSKCC patients who live in or near Brooklyn — which amounts to more than 15 percent of MSKCC's patients currently being treated in Manhattan.
In Switzerland, more than 400,000 people suffer from type 2 diabetes, a serious metabolic disorder that is constantly increasing.
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin can inhibit viral replication by preventing SARS-CoV-2 entry into host cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Carol B Myers, OT 2640 Lloyd Cir, Boulder, CO 80304-2002 Ph: (303) 819-8933 | Ms Carol B Myers, OT 2121 Mesa Dr, Boulder, CO 80304-3621 Ph: (720) 565-2693 |
News Archive
A team led by Fengzhi Li, PhD, and Xinjiang Wang, PhD, of Roswell Park Cancer Institute has reported new findings regarding therapeutic targets of the novel anticancer agent FL118. Previous studies from these researchers have showed that FL118 induces cancer cell death, or apoptosis, by inhibiting expression of multiple cell-survival proteins (survivin, Mcl-1, XIAP or cIAP2).
BHR Pharma, LLC (BHR) announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its proprietary BHR-100 intravenous progesterone infusion product.
Memorial Sloan-Kettering Cancer Center (MSKCC) today celebrated a new outpatient chemotherapy center, which is scheduled to open later this month, pending approval from the State Department of Health. The 7,745-square-foot facility, called the Brooklyn Infusion Center, will provide leading-edge chemotherapy services to current MSKCC patients who live in or near Brooklyn — which amounts to more than 15 percent of MSKCC's patients currently being treated in Manhattan.
In Switzerland, more than 400,000 people suffer from type 2 diabetes, a serious metabolic disorder that is constantly increasing.
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin can inhibit viral replication by preventing SARS-CoV-2 entry into host cells.
› Verified 6 days ago
Kathleen Anne Stumpf, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 303-447-1010 | |
Dhori Meyer Knud-hansen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1100 Balsam Ave, Boulder, CO 80304 Phone: 303-440-2100 | |
Amalia Beard, MOT, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5412 Idylwild Trl, Boulder, CO 80301 Phone: 303-579-6149 | |
Celia Galvin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6214 Willow Ln, Boulder, CO 80301 Phone: 314-882-4569 | |
Courtney Whalen, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4740 Pearl Pkwy, Boulder, CO 80301 Phone: 303-449-2730 | |
Jakki Ruzich, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3850 Paseo Del Prado St Apt 36, Boulder, CO 80301 Phone: 702-612-7533 | |
David Mangine, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7869 Brockway Dr, Boulder, CO 80303 Phone: 303-888-2819 |